Gut Microbiota Market Size

Gut Microbiota Market size was over USD 646.7 Million in 2023 and is expected to exceed USD 5.14 Billion by the end of 2036, growing at over 19.3% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of gut microbiota is evaluated at USD 731.6 Million. The growth of the market can be attributed to the growing focus on the human immunity system post-COVID-19 as people with low immunity were most affected by the pandemic. According to the World Health Organization as of 23^rd March 2023, there have been 761,071,826 confirmed cases of COVID-19 worldwide, which includes 6,879,677 deaths to date. Moreover, the increasing role of gut microbiota in immunity besides the rising research on how to improve gut flora is further expected to boost the market growth.

In addition to these, factors that are believed to fuel the market growth of gut microbiota include soaring investments, and collaboration between major key players to study & develop the human microbiome therapy to the next level. For instance, as per a new Bar-Ilan University study, gut microbes are anticipated to diagnose gestational diabetes as early as the first trimester of pregnancy which is months earlier than typically detected. The rising concern about gestational diabetes mellitus (GDM) worldwide which plagues around 10% of pregnant women across the globe is predicted to present the potential for market expansion over the projected period.